General Information of the Compound
Compound ID
CP0496711
Compound Name
6-(4-(4-(benzo[d][1,3]dioxol-5-ylmethyl)piperazin-1-ylsulfonyl)phenyl)-3-methyl-1-propyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione
    Show/Hide
Structure
Formula
C28H31N5O6S
Molecular Weight
565.652
Canonical SMILES
CCCn1c2cc([nH]c2c(=O)n(C)c1=O)-c1ccc(cc1)S(=O)(=O)N1CCN(Cc2ccc3OCOc3c2)CC1
    Show/Hide
InChI
InChI=1S/C28H31N5O6S/c1-3-10-33-23-16-22(29-26(23)27(34)30(2)28(33)35)20-5-7-21(8-6-20)40(36,37)32-13-11-31(12-14-32)17-19-4-9-24-25(15-19)39-18-38-24/h4-9,15-16,29H,3,10-14,17-18H2,1-2H3
    Show/Hide
InChIKey
DJEKAJRWTYNFPX-UHFFFAOYSA-N
Physicochemical Property
logP
2.3405
Rotatable Bonds
7
Heavy Atom Count
40
Polar Areas
118.87
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
9
Complexity
40

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44413202
ChEMBL ID
CHEMBL211071
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
IC50 = 102 nM
   TI
   LI
   LO
   TS
Protein ID: PT01278, Adenosine receptor A2b
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 = 13 nM
   TI
   LI
   LO
   TS
Protein ID: PT01279, Adenosine receptor A3
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000017 HeLa Homo sapiens (Human)  1
1
IC50 = 14860 nM
   TI
   LI
   LO
   TS